The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
Aug 2: Taiho Oncology picked up a label expansion for its cancer drug Lonsurf (tipiracil), alone or as part of a combination regimen with Roches Avastin (bevacizumab) in metastatic colorectal cancer (mCRC)
Long-term use should be approached cautiously because some patients report mild side effects like nausea or injection site discomfort, and research on prolonged use is limited. To minimize the risk of adverse reactions, always get the injections from a registered physician
Low levels of glutathione are linked to accelerated aging and almost every chronic disease, especially those associated with aging like cognitive decline, type 2 diabetes, and many forms of chronic disease
Therapeutic peptides used in clinical medicine are bioidentical sequences structurally identical to those the body produces naturally that restore specific signalling pathways where production has declined